Amgen executives also said that there was already an approved therapy, deep brain stimulation, that could help alleviate the symptoms of the patients from the clinical trials.
Japanese researchers said Tuesday they had successfully treated monkeys with Parkinson's disease through a stem cell transplant, potentially paving the way for an ideal remedy to the intractable disease.
However, religion groups, right-wing organizations and some ecologists were opposed to embryonic stem cell research, arguing it will open the door for human cloning.
The drug, however, is no longer available to Kaufman or other Parkinson's patients in clinical trials.
